美国领土及自由联系国在新冠疫苗接种推广前六个月加强接种与促进疫苗公平的策略
美国八个领土及自由联系国(TFAS)因地理偏远、社会经济差异、自然灾害频发、接种点有限、采购运输困难及流动人口追踪难等障碍,在新冠疫苗紧急使用授权前制定了针对性接种策略,并在推广前六个月成功实施,改善了疫苗公平。
要点
- TFAS面临地理偏远、社会经济差异、自然灾害、接种点有限、采购运输困难及流动人口追踪难等障碍。
- TFAS在新冠疫苗紧急使用授权前制定了针对性接种策略,确保关键高风险人群及时接种。
- 支持CDC新冠应对的主题专家与合作伙伴合作,通过创新伙伴关系和疫苗分发策略改善了TFAS的疫苗公平。
核心结论
- 通过创新伙伴关系和疫苗分发策略,TFAS在新冠疫苗接种推广期间改善了疫苗公平。
研究设计与样本
- 本文为美国八个领土及自由联系国(TFAS)在新冠疫苗接种推广前六个月实施针对性接种策略的经验总结。
主要发现
- TFAS在新冠疫苗紧急使用授权前制定了针对性接种策略,并在推广前六个月成功实施,确保关键高风险人群及时接种。
- 支持CDC新冠应对的主题专家与合作伙伴合作,在这些辖区预防、发现和应对疫情。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The eight U.S. territories and freely associated states (TFAS) have historically faced unique social and structural barriers in the implementation of vaccination programs due to geographic remoteness, a high prevalence of socioeconomic disparities, increasing prevalence of natural disasters, limited vaccine providers and clinics, difficulties with procurement and shipping, and difficulty tracking highly mobile populations. In the months leading up to emergency authorizations for the use of COVID-19 vaccines, the TFAS developed tailored vaccination strategies to ensure that key at-risk populations received timely vaccination, and successfully implemented these strategies during the first six months of the vaccine rollout. Subject matter experts supporting the Centers for Disease Control and Prevention's COVID-19 Response recognized the unique historical, geographic, social, and cultural dynamics for residents in the TFAS and worked with partners to prevent, detect, and respond to the pandemic in these jurisdictions. As a result of innovative partnerships and vaccine distribution strategies, vaccine equity was improved in the TFAS during the COVID-19 vaccine rollout.
引用
- Tippins A, Acevedo JC, Palomeque FS, et al. Strategies to strengthen COVID-19 vaccine uptake and improve vaccine equity in U.S. Territories and Freely Associated States during the first six months of vaccine rollout. Vaccine. 2024. PMID: 38719692. doi:10.1016/j.vaccine.2024.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。